• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Helix BioMedix Inc

  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Disease Focus
    • DNA Damage Response (DDR)
    • Xeroderma Pigmentosum
  • Programs
    • Pharma
    • Personal Care
  • News
    • Press Releases
    • Presentations
    • Scientific Publications
  • Investors
    • Stock Information
    • IR Updates
    • Proxy
    • Corporate Governance
  • Contact Page
You are here: Home / Investors / Stock Information

Stock Information

Helix BioMedix (PK:HXBM)

Recently there have been changes related to the OTC Bulletin Board electronic quotation platform that have made it somewhat confusing for investors to obtain a stock quote for Helix BioMedix and many other OTCBB companies.  A press release that we previously issued  explains these changes. In addition, we direct you to the following websites for accessing an accurate stock quote for Helix BioMedix:

Company Name 

Yahoo Finance (www.finance.yahoo.com)

Trading Symbol

HXBM

 Quote

Get Quote Now

TRANSFER AGENT
Broadridge Financial Solutions, Inc.

Website: www.shareholder.broadridge.com
E-mail: shareholder@broadridge.com
Telephone: 1-877-830-4936 or 720-378-5591

Mail: Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717

INVESTOR RELATIONS CONTACT
E-mail: ir@helixbiomedix.com
Telephone: 425.402.8400

 

Primary Sidebar

Footer

COMPANY PROFILE

Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum.  Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.

 

 

 

 

Terms & Conditions | Privacy Policy

Search

 

©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Copyright © 2025 · Executive Pro On Genesis Framework · WordPress · Log in